RESUMO
In this work, we report the construction of a novel electrochemical device for molecular diagnosis of hepatitis B virus in the blood plasma of infected patients, using graphite electrodes functionalized with poly(4-aminophenol) and sensitized with a specific DNA probe. The recognition of genomic DNA was evaluated by electrochemical techniques (DPV and EIS) and scanning electron microscopy. The genosensor was efficient in detecting genomic DNA with a linear range from 1.176 to 4.825 µg mL-1 and detection limit of 35.69 ng mL-1 (4.63 IU ml-1 or 25.93 copies.ml-1), which is better than the 10.00 IU ml-1 limit of reference method, real-time PCR, used in point of care. EIS analysis shows that the genosensor resistance increased exponentially with the concentration of the genomic DNA target. This novel platform has advantages to its applicability in real samples, such as good sensitivity, selectivity, low sample volume, and fast assay time (36 min), thus interesting for application in the diagnosis of hepatitis B virus in blood plasma. Also, the ease of synthesis of the low-cost polymer by electrosynthesis directly on the electrode surface allows the translation of the platform to portable devices.
Assuntos
Técnicas Biossensoriais , Grafite , Hepatite B , Técnicas Biossensoriais/métodos , DNA/química , Técnicas Eletroquímicas/métodos , Eletrodos , Grafite/química , Hepatite B/diagnóstico , Vírus da Hepatite B/genética , Humanos , Limite de Detecção , PlasmaRESUMO
BACKGROUND: Rheumatoid arthritis is the most common inflammatory autoimmune disease in the world. Recently new targets for its detection were developed as alternatives to classic biomarkers, including the M-12 peptide, that mimics carbonic anhydrase III. Thus, the application of this peptide for the development of new detection devices is attractive. OBJECTIVE: Our goal was to construct a modified electrode for immobilization of M-12 peptide and detection of a rheumatoid arthritis biomarker in serum of patients. METHODS: 3-Hydroxybenzoic acid was electropolymerized onto graphite electrodes, and M-12 peptide was immobilized by adsorption. Negative and positive serum samples for rheumatoid arthritis were diluted and applied onto the electrode. Detection was carried in potassium ferrocyanide/ ferricyanide solution by differential pulse voltammetry. Atomic force microscopy and scanning electron microscopy were used to evaluate electrode surfaces. RESULTS: Cyclic voltammograms indicated the poly(3-hydroxybenzoic acid) formation and increase of electroactive area. Immobilization of M-12 probe increased current by 1.2 times, and negative serum addition caused no suitable difference. However, positive serum showed expressive decrease in the current signal of about 2.2 times, possibly due to steric hindrance when the anti-CA3 antibody interacts with the M-12 peptide, decreasing the electron transfer. Microscopies images corroborated with the electrochemical detection, showing evident changes in the morphology of the electrode surfaces. CONCLUSION: The bioelectrode was able to discriminate positive and negative serum samples of rheumatoid arthritis by a considerable decrease in the current signal value. Morphological analyses supported the electrochemical results. Thus, the constructed bioelectrode offers a new platform for detection of rheumatoid arthritis.